Latest Safety News

Page 161 of 194
Radiopharm Theranostics has secured Data Safety and Monitoring Committee approval to escalate dosing in its Phase 1 trial of 177Lu-RAD204, expanding patient cohorts across multiple cancer types.
Ada Torres
Ada Torres
12 May 2025
Dyno Nobel Limited reported a $25 million EBIT uplift in its 2025 half-year results, driven by its ongoing transformation program and strategic moves to separate its Fertilisers business. Despite weather-related challenges, the company is progressing key asset sales and preparing for a share buyback resumption.
Maxwell Dee
Maxwell Dee
12 May 2025
Dyno Nobel Limited reports a statutory net profit of $7 million for 1H25, reversing a prior loss, as it advances key sales agreements to separate its Fertilisers business and accelerates its transformation program.
Victor Sage
Victor Sage
12 May 2025
Austco Healthcare has renewed its preferred supplier agreement with a major US healthcare provider, continuing supply of its Tacera nurse call systems to 180 hospitals across 30 states. This extension builds on a lucrative five-year partnership worth over A$49 million.
Ada Torres
Ada Torres
9 May 2025
Torque Metals has won a $144,500 co-funded drilling grant from the Western Australian government to explore down-plunge extensions of high-grade gold at its Paris Gold Project, potentially expanding its resource base.
Maxwell Dee
Maxwell Dee
8 May 2025
Nyrada’s experimental drug NYR-BI03 shows promising cardioprotective and anti-arrhythmic effects in animal models, reinforcing its potential as a treatment for acute myocardial infarction.
Ada Torres
Ada Torres
8 May 2025
Transurban Group is streamlining operations with a workforce reduction of around 300 roles, targeting over $50 million in annual cost savings while maintaining its FY25 distribution guidance.
Nora Hopper
Nora Hopper
8 May 2025
Transurban Group is streamlining operations with a workforce reduction of approximately 300 employees, aiming to save over $50 million annually while maintaining its FY25 distribution guidance.
Nora Hopper
Nora Hopper
8 May 2025
Orica Limited reported its strongest half-year EBIT in over a decade, driven by robust demand for premium blasting products and technology adoption, alongside significant safety and sustainability achievements.
Maxwell Dee
Maxwell Dee
8 May 2025
Orica Limited reported a robust first half FY2025 with a 40% rise in NPAT pre-significant items and strong cash flow, underpinned by demand for premium blasting and digital solutions. The company also announced a $400 million share buy-back and a 32% higher interim dividend.
Maxwell Dee
Maxwell Dee
8 May 2025
Spectur Limited appoints Anthony Schmidt as CEO, accelerating its transition to a scalable SaaS model and targeting operational cashflow neutrality by mid-2025 amid a $3 billion addressable market.
Sophie Babbage
Sophie Babbage
7 May 2025
Alterity Therapeutics is set to present compelling Phase 2 clinical trial results for ATH434 at the 2025 International Multiple System Atrophy Congress, highlighting slowed disease progression and biomarker engagement in MSA patients.
Ada Torres
Ada Torres
7 May 2025